Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ganga Gopinathan

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Plos One|March 7, 2012
Blocking autophagy prevents bortezomib-induced NF-κB activation by reducing I-κBα degradation in lymphoma cellsLi Jia, Ganga Gopinathan, Johanna T Sukumar, et al.
Molecular Cancer Therapeutics|March 21, 2022
Immune Mechanisms of Resistance to Cediranib in Ovarian CancerGanga Gopinathan, Chiara Berlato, Anissa Lakhani, et al.
Cancer Research|February 12, 2015
Adaptive Upregulation of EGFR Limits Attenuation of Tumor Growth by Neutralizing IL6 Antibodies, with Implications for Combined Therapy in Ovarian CancerCarla S Milagre, Ganga Gopinathan, Gemma Everitt, et al.
Cancer Research|June 18, 2015
Interleukin-6 Stimulates Defective AngiogenesisGanga Gopinathan, Carla Milagre, Oliver M T Pearce, et al.
Cell Reports|January 16, 2020
Mouse Ovarian Cancer Models Recapitulate the Human Tumor Microenvironment and Patient Response to TreatmentEleni Maniati, Chiara Berlato, Ganga Gopinathan, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Plos One|March 7, 2012
Blocking autophagy prevents bortezomib-induced NF-κB activation by reducing I-κBα degradation in lymphoma cellsLi Jia, Ganga Gopinathan, Johanna T Sukumar, et al.
Molecular Cancer Therapeutics|March 21, 2022
Immune Mechanisms of Resistance to Cediranib in Ovarian CancerGanga Gopinathan, Chiara Berlato, Anissa Lakhani, et al.
Cancer Research|February 12, 2015
Adaptive Upregulation of EGFR Limits Attenuation of Tumor Growth by Neutralizing IL6 Antibodies, with Implications for Combined Therapy in Ovarian CancerCarla S Milagre, Ganga Gopinathan, Gemma Everitt, et al.
Cancer Research|June 18, 2015
Interleukin-6 Stimulates Defective AngiogenesisGanga Gopinathan, Carla Milagre, Oliver M T Pearce, et al.
Cell Reports|January 16, 2020
Mouse Ovarian Cancer Models Recapitulate the Human Tumor Microenvironment and Patient Response to TreatmentEleni Maniati, Chiara Berlato, Ganga Gopinathan, et al.
Pageof 1